Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q1 Loss, Tops Revenue Estimates

Kiniksa Pharmaceuticals, Ltd. (KNSA) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.18 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -78.57%. A quarter ago, it was expected that this company would post a loss of $0.11 per share when it actually produced earnings of $0.04, delivering a surprise of 136.36%.Over the last four quarters, the co ...